Imidazoquinoxaline Derivative EAPB0503: A Promising Drug Targeting Mutant Nucleophosmin 1 in Acute Myeloid Leukemia
Cancer - United States
doi 10.1002/cncr.30515
Full Text
Open PDFAbstract
Available in full text
Date
January 5, 2017
Authors
Publisher
Wiley